This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Mylan Institutional LLC
Mylan Institutional LLC, a prominent player in the pharmaceutical industry, is headquartered in Ireland (IE) and operates extensively across various global markets. Founded in 1961, the company has established itself as a leader in providing high-quality generic and specialty medications, particularly in the institutional healthcare sector. Mylan Institutional focuses on delivering a diverse range of injectable and non-injectable products, catering to hospitals and healthcare providers. Its commitment to quality and affordability sets it apart in a competitive landscape. Over the years, Mylan has achieved significant milestones, including strategic partnerships and a robust product portfolio that addresses critical healthcare needs. With a strong market position, Mylan Institutional is recognised for its innovative solutions and dedication to improving patient outcomes, making it a trusted name in the pharmaceutical field.
DitchCarbon Score
How does Mylan Institutional LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mylan Institutional LLC's score of 45 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mylan Institutional LLC, headquartered in Ireland (IE), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Viatris Inc., which may influence its climate commitments and reporting practices. As part of its corporate family, Mylan's climate initiatives and reduction targets are likely aligned with those of Viatris Inc. However, specific reduction targets or achievements have not been disclosed for Mylan. The absence of documented reduction initiatives suggests that Mylan may still be in the process of establishing its own climate strategy or reporting framework. Mylan's climate commitments may be informed by Viatris Inc.'s broader sustainability goals, which could include participation in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, without specific data or targets from Mylan, it is challenging to provide a detailed overview of its carbon emissions and climate commitments. In summary, Mylan Institutional LLC currently lacks specific emissions data and reduction targets, with its climate strategy potentially influenced by its parent company, Viatris Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 302,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 354,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mylan Institutional LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
